Wellgistics Health Plans to Develop PharmacyChain Smart-Contract Drug Tracking on Multiple Blockchain Platforms and Target In-Pharmacy Deployment by Q2 2026, with Broader Rollout to Its Pharmacy Network Later in 2026

Reuters03-05
Wellgistics Health Plans to Develop PharmacyChain Smart-Contract Drug Tracking on Multiple Blockchain Platforms and Target In-Pharmacy Deployment by <a href="https://laohu8.com/S/QTWO">Q2</a> 2026, with Broader Rollout to Its Pharmacy Network Later in 2026

Wellgistics Health Inc. said it plans to develop its PharmacyChain smart contracts-enabled pharmaceutical drug tracking system using multiple blockchain platforms, including Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu and Corda. The company aims to make the system operational first within its own Wellgistics Pharmacy by the end of the second quarter of 2026, with the goal of enabling closed-loop, HIPAA-compliant data transfers and supporting drug serialization requirements such as the DSCSA. Wellgistics also plans to later offer PharmacyChain to pharmacies in its network and to build options that can integrate data from other healthcare ecosystem participants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202603050740ACCESSWRNAPR_____1143982) on March 05, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment